Other Species / Isoforms
  RBM7 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K45
KVKIPKDKDGKLKQF
0 1
RBM7 (human) KVKIPKDkDGkPkQF K45-m2
RBM7 (mouse) KVKIPKDKDGKLKQF K45
RBM7 (rat) gap -
K48
IPKDKDGKLKQFAFV
0 1
RBM7 (human) IPKDkDGkPkQFAFV K48-ac
RBM7 (mouse) IPKDKDGKLKQFAFV K48
RBM7 (rat) gap -
K50
KDKDGKLKQFAFVNF
0 1
RBM7 (human) KDkDGkPkQFAFVNF K50-ac
RBM7 (mouse) KDKDGKLKQFAFVNF K50
RBM7 (rat) gap -
K58
QFAFVNFKHEVSVPY
0 1
RBM7 (human) QFAFVNFkHEVSVPY K58-ac
RBM7 (mouse) QFAFVNFKHEVSVPY K58
RBM7 (rat) gap -
K81
KLFGRPIKIQFRSGS
0 1
RBM7 (human) KLYGRPIkIQFRSGS K81-ub
RBM7 (mouse) KLFGRPIKIQFRSGS K81
RBM7 (rat) KLFGRPIKIQFRSGS K15
L107
PQHHVGNLsPtSTSP
0 20
RBM7 (human) PQHHVGNssPtstsP S107-p
RBM7 (mouse) PQHHVGNLsPtSTSP L107
RBM7 (rat) PQHHMGNLSPTSTSP L41
S108-p
QHHVGNLsPtSTSPN
Upstream
1 23
Treatment
  • insulin
RBM7 (human) QHHVGNssPtstsPS S108-p
RBM7 (mouse) QHHVGNLsPtSTSPN S108-p
RBM7 (rat) QHHMGNLSPTSTSPN S42
T110-p
HVGNLsPtSTSPNSY
1 4
RBM7 (human) HVGNssPtstsPSRY T110-p
RBM7 (mouse) HVGNLsPtSTSPNSY T110-p
RBM7 (rat) HMGNLSPTSTSPNSY T44
S111
VGNLsPtSTSPNSYE
0 1
RBM7 (human) VGNssPtstsPSRYE S111-p
RBM7 (mouse) VGNLsPtSTSPNSYE S111
RBM7 (rat) MGNLSPTSTSPNSYE S45
T112
GNLsPtSTSPNSYER
0 1
RBM7 (human) GNssPtstsPSRYER T112-p
RBM7 (mouse) GNLsPtSTSPNSYER T112
RBM7 (rat) GNLSPTSTSPNSYER T46
S113
NLsPtSTSPNSYERt
0 8
RBM7 (human) NssPtstsPSRYERT S113-p
RBM7 (mouse) NLsPtSTSPNSYERt S113
RBM7 (rat) NLSPTSTSPNSYERT S47
T120-p
SPNSYERtVGNVsPt
0 1
RBM7 (human) sPSRYERTMDNMTsS T120
RBM7 (mouse) SPNSYERtVGNVsPt T120-p
RBM7 (rat) SPNSYERTVGNVTPP T54
S125-p
ERtVGNVsPtAQMVQ
0 8
RBM7 (human) ERTMDNMTsSAQIIQ T125
RBM7 (mouse) ERtVGNVsPtAQMVQ S125-p
RBM7 (rat) ERTVGNVTPPAQMVQ T59
P126
RtVGNVsPtAQMVQR
0 1
RBM7 (human) RTMDNMTsSAQIIQR S126-p
RBM7 (mouse) RtVGNVsPtAQMVQR P126
RBM7 (rat) RTVGNVTPPAQMVQR P60
T127-p
tVGNVsPtAQMVQRS
0 1
RBM7 (human) TMDNMTsSAQIIQRs S127
RBM7 (mouse) tVGNVsPtAQMVQRS T127-p
RBM7 (rat) TVGNVTPPAQMVQRS P61
S134
tAQMVQRSFssPEDY
0 5
RBM7 (human) SAQIIQRsFssPENF S134-p
RBM7 (mouse) tAQMVQRSFssPEDY S134
RBM7 (rat) PAQMVQRSFsTPEDY S68
S136-p
QMVQRSFssPEDYQR
Upstream
Downstream
2 153
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • MAPKAPK2 (human)
Treatment
  • anisomycin
  • BIRB-0796
  • IL-33
  • insulin
  • ischemia
  • LCMV_gp33-41_peptide
  • LPS
  • LY294002
RBM7 (human) QIIQRsFssPENFQr S136-p
RBM7 (mouse) QMVQRSFssPEDYQR S136-p
RBM7 (rat) QMVQRSFsTPEDYQR S70-p
S137-p
MVQRSFssPEDYQRQ
0 33
RBM7 (human) IIQRsFssPENFQrQ S137-p
RBM7 (mouse) MVQRSFssPEDYQRQ S137-p
RBM7 (rat) MVQRSFsTPEDYQRQ T71
R143
ssPEDYQRQAVMNSV
0 1
RBM7 (human) ssPENFQrQAVMNsA R143-m1
RBM7 (mouse) ssPEDYQRQAVMNSV R143
RBM7 (rat) sTPEDYQRQAVMNSV R77
S149
QRQAVMNSVFRQMSY
0 4
RBM7 (human) QrQAVMNsALrQMsY S149-p
RBM7 (mouse) QRQAVMNSVFRQMSY S149
RBM7 (rat) QRQAVMNSVFRQMSY S83
R152
AVMNSVFRQMSYAGK
0 6
RBM7 (human) AVMNsALrQMsYGGK R152-m1
RBM7 (mouse) AVMNSVFRQMSYAGK R152
RBM7 (rat) AVMNSVFRQMSYVGK R86
S155
NSVFRQMSYAGKFGS
0 7
RBM7 (human) NsALrQMsYGGKFGS S155-p
RBM7 (mouse) NSVFRQMSYAGKFGS S155
RBM7 (rat) NSVFRQMSYVGKFGS S89
P163
YAGKFGSPHADQLGF
0 2
RBM7 (human) YGGKFGSsPLDQsGF S163-p
RBM7 (mouse) YAGKFGSPHADQLGF P163
RBM7 (rat) YVGKFGSPHADQLGF P97
L168
GSPHADQLGFsPSAQ
0 1
RBM7 (human) GSsPLDQsGFsPSVQ S168-p
RBM7 (mouse) GSPHADQLGFsPSAQ L168
RBM7 (rat) GSPHADQLGFSPSVQ L102
S171-p
HADQLGFsPSAQPHG
0 3
RBM7 (human) PLDQsGFsPSVQSHs S171-p
RBM7 (mouse) HADQLGFsPSAQPHG S171-p
RBM7 (rat) HADQLGFSPSVQPHG S105
G178
sPSAQPHGHTFNQSS
0 1
RBM7 (human) sPSVQSHsHsFNQSS S178-p
RBM7 (mouse) sPSAQPHGHTFNQSS G178
RBM7 (rat) SPSVQPHGHTFNQSS G112
T180
SAQPHGHTFNQSSSS
0 2
RBM7 (human) SVQSHsHsFNQSSSS S180-p
RBM7 (mouse) SAQPHGHTFNQSSSS T180
RBM7 (rat) SVQPHGHTFNQSSSS T114
R190
QSSSSQWRQDALSSQ
0 4
RBM7 (human) QSSSSQWrQGTPSSQ R190-m1
RBM7 (mouse) QSSSSQWRQDALSSQ R190
RBM7 (rat) QSSSSQWRQDAVSSQ R124
R190
QSSSSQWRQDALSSQ
0 1
RBM7 (human) QSSSSQWrQGTPSSQ R190-m2
RBM7 (mouse) QSSSSQWRQDALSSQ R190
RBM7 (rat) QSSSSQWRQDAVSSQ R124
R198
QDALSSQRKRQNsHP
0 1
RBM7 (human) QGTPSSQrkVrMNsy R198-m1
RBM7 (mouse) QDALSSQRKRQNsHP R198
RBM7 (rat) QDAVSSQRKRQNSHP R132
R198
QDALSSQRKRQNsHP
0 1
RBM7 (human) QGTPSSQrkVrMNsy R198-m2
RBM7 (mouse) QDALSSQRKRQNsHP R198
RBM7 (rat) QDAVSSQRKRQNSHP R132
K199
DALSSQRKRQNsHPY
0 1
RBM7 (human) GTPSSQrkVrMNsyP K199-m1
RBM7 (mouse) DALSSQRKRQNsHPY K199
RBM7 (rat) DAVSSQRKRQNSHPY K133
R200
ALSSQRKRQNsHPYL
0 7
RBM7 (human) PSSQrkVrMNsyPYL R201-m1
RBM7 (mouse) ALSSQRKRQNsHPYL R200
RBM7 (rat) AVSSQRKRQNSHPYL R134
S203-p
SQRKRQNsHPYLADR
Upstream
1 82
Treatment
  • IL-33
  • insulin
  • MK-2206
RBM7 (human) QrkVrMNsyPYLADr S204-p
RBM7 (mouse) SQRKRQNsHPYLADR S203-p
RBM7 (rat) SQRKRQNSHPYLADR S137
H204
QRKRQNsHPYLADRH
0 1
RBM7 (human) rkVrMNsyPYLADrH Y205-p
RBM7 (mouse) QRKRQNsHPYLADRH H204
RBM7 (rat) QRKRQNSHPYLADRH H138
R210
sHPYLADRHYSREQR
0 1
RBM7 (human) syPYLADrHYSREQR R211-m1
RBM7 (mouse) sHPYLADRHYSREQR R210
RBM7 (rat) SHPYLADRHYSREQR R144
R228
HGSDYHYRGSREDFY
0 2
RBM7 (human) HGSDHHYrGKRDDFF R229-m1
RBM7 (mouse) HGSDYHYRGSREDFY R228
RBM7 (rat) HGSDYHYRGGREDFY R162
K259
RDSSRGGKWPSSRH_
0 1
RBM7 (human) RDSSRDGkWRSSRH_ K260-ac
RBM7 (mouse) RDSSRGGKWPSSRH_ K259
RBM7 (rat) RDSSRGGKWPSSRH_ K193